510(k) device
Neurolac(R) Nerve Guide
Polyganics B.V. · Cuff, Nerve (JXI, Class II) · First FDA decision Oct 10, 2003, newest Oct 20, 2011Peripheral neuropathy and nerve injury
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
2
Naming "Neurolac"
MAUDE reports
4
Brand "Neurolac", since 2015
PubMed studies
20
Mentioning "Neurolac"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Neurolac(R) Nerve Guide
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- NEUROLAC(R) NERVE GUIDE510(k)
K112267 · Decided Oct 20, 2011 · 73 days after receipt
Device type: Cuff, Nerve (JXI) · Neurology & Neurosurgery
- NEUROLAC NERVE GUIDE510(k)
K050573 · Decided May 4, 2005 · 58 days after receipt
Device type: Cuff, Nerve (JXI) · Neurology & Neurosurgery
K032115 · Decided Oct 10, 2003 · 93 days after receipt
Device type: Cuff, Nerve (JXI) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Vagus Nerve Stimulation (VNS)National determinationOn the books160.18Updated Nov 5, 2026
- Vagus Nerve Stimulation for Treatment of Resistant Depression (TRD)National analysisReview closedCAG-00313RUpdated Sep 24, 2026
- Vagus Nerve Stimulation (VNS) for Treatment Resistant Depression (TRD)National analysisReview closedCAG-00313R2Updated Sep 24, 2026
- Transcutaneous Electrical Nerve Stimulation for Chronic Low Back PainNational analysisReview closedCAG-00429NUpdated Sep 24, 2026
- Cavernous Nerves Electrical Stimulation with Penile PlethysmographyNational analysisReview closedCAG-00311NUpdated Sep 17, 2026
- Sacral Nerve Stimulation for Urge Urinary IncontinenceNational analysisReview closedCAG-00058NUpdated Sep 15, 2026
- Electrodiagnostic Sensory Nerve Conduction ThresholdNational analysisReview closedCAG-00106RUpdated Sep 14, 2026
- Electrodiagnostic Sensory Nerve Conduction ThresholdNational analysisReview closedCAG-00106NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Neurolac", any status and sponsor, newest update first.
- A Comparative Post-marketing Study of Commercially Available Peripheral Nerve Gap Repair OptionsTerminated
Axogen CorporationNot on our public-company list
NCT00948025 · 23 participants · Start Jun 2009 · Primary completion Dec 2014
Device: Hollow tube nerve conduit, synthetic or biosynthetic · For: Traumatic Nerve Injury
Sites: Atlanta, Georgia; Indianapolis, Indiana; Lexington, Kentucky · 4 sites in all
Polyganics BVNot on our public-company list
NCT02993276 · 73 participants · Start Apr 17, 2017 · Primary completion Jul 6, 2018
Device: Neurocap® · For: Neuroma
Sites: Phoenix, Arizona; Redwood City, California; San Francisco, California · 16 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Neurolac", and for the whole product code for context.
This brand
4 reports: 0 malfunction, 4 injury, 0 death
Whole product code JXI
127 reports: 19 malfunction, 106 injury, 0 death
Newest reports for this brand
- NEUROLACInjury
3004504732-2022-00001 · Received Aug 17, 2023 · Event dated Oct 21, 2022
Device type: Cuff, Nerve (JXI)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Peripheral Nervous Injury
- NEUROLACInjury
3004504732-2018-00003 · Received Aug 22, 2019 · Event dated Feb 27, 2018
Device type: Cuff, Nerve (JXI)
Device problem as coded: Appropriate Device Problem Term/Code Not Available
Patient problem as coded: Swelling
- NEUROLACInjury
3004504732-2018-00002 · Received Jun 1, 2018 · Event dated Apr 11, 2018
Device type: Cuff, Nerve (JXI)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Swelling; Numbness
1 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Neurolac"[tiab]. The summary above synthesizes these.
- Composition-property relationships for an experimental composite nerve guidance conduit: evaluating cytotoxicity and initial tensile strength.
Kehoe S, Zhang XF, Boyd D · J Mater Sci Mater Med · 2011Research Support, Non-U.S. Gov't
- PREVENTION OF SYMPTOMATIC NEUROMA BY USING SYNTHETIC CONDUITS IN FINGER AMPUTATION STUMPS.
Wataya EY, Lopes DB, Takazono DK, et al. · Acta Ortop Bras · 2025
- PLGA 90/10 and caprolactone biodegradable nerve guides for the reconstruction of the rat sciatic nerve.
Luis AL, Rodrigues JM, Amado S, et al. · Microsurgery · 2007
- Micro-nanofiber composite biomimetic conduits promote long-gap peripheral nerve regeneration in canine models.
Dong X, Yang Y, Bao Z, et al. · Bioact Mater · 2023
- Porosity of the wall of a Neurolac nerve conduit hampers nerve regeneration.
Meek MF, Den Dunnen WF · Microsurgery · 2009Comparative Study
- A prospective clinical evaluation of biodegradable neurolac nerve guides for sensory nerve repair in the hand.
Bertleff MJ, Meek MF, Nicolai JP · J Hand Surg Am · 2005Clinical Trial, Multicenter Study
- Bioresorbable and Mechanically Optimized Nerve Guidance Conduit Based on a Naturally Derived Medium Chain Length Polyhydroxyalkanoate and Poly(ε-Caprolactone) Blend.
Mendibil X, González-Pérez F, Bazan X, et al. · ACS Biomater Sci Eng · 2021Research Support, Non-U.S. Gov't
- [The employment of synthetic biodegradable polymers in reconstructions of the peripheral nerves].
Gosk J, Urban M, Ratajczak K, et al. · Polim Med · 2010English Abstract, Review
- Innovative spiral nerve conduits: Addressing nutrient transport and cellular activity for critical-sized nerve defects.
Zennifer A, Praveenn Kumar SK, Bagewadi S, et al. · Bioact Mater · 2025
- Clinical Evaluation After Peripheral Nerve Repair With Caprolactone Neurotube.
Costa Serrão de Araújo G, Couto Neto B, Harley Santos Botelho R, et al. · Hand (N Y) · 2017Evaluation Study
- Experience of using the bioresorbable copolyester poly(DL-lactide-ε-caprolactone) nerve conduit guide Neurolacࡊ for nerve repair in peripheral nerve defects: report on a series of 28 lesions.
Chiriac S, Facca S, Diaconu M, et al. · J Hand Surg Eur Vol · 2012
- Evaluation of two biodegradable nerve guides for the reconstruction of the rat sciatic nerve.
Luis AL, Rodrigues JM, Lobato JV, et al. · Biomed Mater Eng · 2007Comparative Study, Evaluation Study
Other devices of this type
Also filed under product code JXI.
- VersaWrap Nerve Protector (VTP-2201)Alafair Biosciences · 510(k) 2025
- Axoguard HA+ Nerve Protector (AGHA12)Axogen Corporation · 510(k) 2023
- Reaxon PlusMedovent GmbH · 510(k) 2018
- NeuraGen 3D Nerve Guide MatrixIntegra LifeSciences Corporation · 510(k) 2017
- Collagen Nerve WrapCollagen Matrix, Inc. · 510(k) 2006
- SILKBridgeKLISBio S.r.l. · 510(k) 2026
- NeuroSpan BridgeAuxilium Biotechnologies, Inc. · 510(k) 2026
- VersaCoat Nerve Protector (VTP-44G2)Alafair Biosciences · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.